Who backs Hyku Biosciences?
7 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| KB Investment | Venture capital |
| Novartis Venture Fund | Other |
| Chugai Venture Fund | — |
| Droia Ventures | — |
| Eisai Innovation | — |
| The Mark Foundation for Cancer Research | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Hyku Biosciences investors
7 investors are on record for Hyku Biosciences, including RA Capital Management, KB Investment, Novartis Venture Fund and Chugai Venture Fund. The debt round in Dec 2025 drew 8 investors.
Free account
More of Hyku Biosciences with a free account
- ·Watch Hyku Biosciences: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 7 firms already write checks for companies like Hyku Biosciences in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View